Effects on thrombin generation of the platelet glycoprotein IIB/IIIa inhibitors abciximab versus tirofiban during coronary intervention (vol 88, pg 1231, 2001)

被引：0
|
作者：
Ambrose, JA
Doss, R
Geagea, JPM
Hawkey, MC
Duvuri, S
Giedd, K
Dominguez, A
Coppola, J
Nguyen, TH
Palla, V
Gould, RB
Barua, RS
Saha, DC
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：722 / 722
页数：1
相关论文
共 50 条
  • [21] Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
    Zarina Habibi
    Jasper Luijkx
    Ben C. G. Gho
    Mustafa Ilhan
    Leo F. Veenstra
    Lex A. W. Ruiters
    Mera Stein
    Arnoud W. J. van ’t Hof
    Saman Rasoul
    Netherlands Heart Journal, 2023, 31 : 426 - 433
  • [22] A pooled analysis of 3 trials of Bivalirudin versus Heparin and Glycoprotein IIb/IIIa inhibitors during Percutaneous Coronary Intervention
    Kalyanasundaram, Arun
    Sartorius, Jennifer
    Scott, Thomas
    Blankenship, James C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 79I - 80I
  • [23] Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous' coronary intervention
    Robertson, Jason O.
    Lincoff, A. Michael
    Wolski, Kathy
    Topol, Eric J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (12): : 1679 - 1684
  • [24] Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
    Xin Zhao
    Xiao-Xu Yang
    Su-Zhen Ji
    Xiao-Zeng Wang
    Li Wang
    Chong-Huai Gu
    Li-Li Ren
    Ya-Ling Han
    Military Medical Research, 2016, (02) : 73 - 79
  • [25] Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
    Zhao X.
    Yang X.-X.
    Ji S.-Z.
    Wang X.-Z.
    Wang L.
    Gu C.-H.
    Ren L.-L.
    Han Y.-L.
    Military Medical Research, 3 (1)
  • [26] Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention - Focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide
    Gilchrist, IC
    CLINICAL PHARMACOKINETICS, 2003, 42 (08) : 703 - 720
  • [27] The Relative Effects of Abciximab and Tirofiban on Platelet Inhibition and C-Reactive Protein during Coronary Intervention
    Saltzman, Adam J.
    Mehran, Roxana
    Hooper, W. Craig
    Moses, Jeffrey W.
    Weisz, Giora
    Collins, Michael B.
    Lansky, Alexandra J.
    Kreps, Edward M.
    Leon, Martin B.
    Stone, Gregg W.
    Dangas, George
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (01): : 2 - 6
  • [28] Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis
    Rukshin, V
    Shah, PK
    Cercek, B
    Finkelstein, A
    Tsang, V
    Kaul, S
    CIRCULATION, 2002, 105 (16) : 1970 - 1975
  • [29] Real-World Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors during Percutaneous Coronary Intervention
    Casterella, Peter J.
    Revenaugh, James R.
    Burke, James L.
    Pearson, Robert R.
    Bair, Tami L.
    May, Heidi T.
    Horne, Benjamin
    Anderson, Jeffrey L.
    Muhlestein, Joseph B.
    JOURNAL OF INVASIVE CARDIOLOGY, 2008, 20 (03): : 94 - 98
  • [30] Interventional cardiology - Bolus-only versus bolus plus infusion of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention
    Kini, Annapoorna S.
    Chen, Victor H. T.
    Krishnan, Prakash
    Lee, Paul
    Kim, Michael C.
    Mares, Angelica
    Suleman, Javed
    Moreno, Pedro R.
    Sharma, Samin K.
    AMERICAN HEART JOURNAL, 2008, 156 (03) : 513 - 519
12345